RE:RE:RE:RE:RE:RE:RE:RE:RE:right on boysAgree, I've always been a supporter of growing the business the right way, but we also need to be relevant and competing for our legitimate place within the industry.
With this bull run and if we have a strong Q2, this stock should reach the $1.50 to $2.00 range heading to Q3. I've always utilized Organigram as a gauge even if they were always a step ahead. Once Supreme is at full capacity I believe we'll be a competitor, so if they're at $5.15, I strongly believe we should be at least at the $2.00 if Q2 supports the increase in SP. We all know the bull run will not last forever and there will be pull back, but if we're at proper valuation and SP the company should be able to continue growing.
Cannabis will be a money making industry and will keep growing for many years to come, and if Supreme gets the recognition it deserves, I strongly believe in its growth.
I realize I was supporting .40 to .60, but things have changed dramatically within the industry lately.
We need to keep on smashing those walls.
IMHO